Skip to main content

MoneyWorks4Me

Sun Pharmaceutical Industries submits press release

06 Nov 2019 Evaluate

Sun Pharmaceutical Industries has informed about submission of its press release relating to License Agreement with AstraZeneca for Novel Oncology products in China, which it shall be releasing after sending this letter.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1760.00
Dr. Reddys Labs. 1305.00
Cipla 1350.00
Lupin 1959.05
Zydus Lifesciences 1167.00
View more..